<?xml version="1.0" encoding="UTF-8"?>
<ref id="B190">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Petsch</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Schnee</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vogel</surname>
    <given-names>A. B.</given-names>
   </name>
   <name>
    <surname>Lange</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Hoffmann</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Voss</surname>
    <given-names>D.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2012</year>). 
  <article-title>Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection</article-title>. 
  <source>Nat. Biotechnol.</source>
  <volume>30</volume>, 
  <fpage>1210</fpage>â€“
  <lpage>1216</lpage>. 
  <pub-id pub-id-type="doi">10.1038/nbt.2436</pub-id>
  <?supplied-pmid 23159882?>
  <pub-id pub-id-type="pmid">23159882</pub-id>
 </mixed-citation>
</ref>
